Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/26/2005EP1587541A2 Compositions and methods of tolerizing a primate to an antigen
10/26/2005EP1587540A2 IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
10/26/2005EP1587536A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface
10/26/2005EP1587524A2 Compositions and methods for targeted biological delivery of molecular carriers
10/26/2005EP1587483A2 Methods for modulating an inflammatory response
10/26/2005EP1587476A2 Novel compositions and methods in cancer
10/26/2005EP1587409A2 Diagnosis and monitoring of inflammation, ischemia and appendicitis
10/26/2005EP1587405A2 Novel compositions and methods for cancer
10/26/2005EP1480675A4 Immunoglobulin purification
10/26/2005EP1230396B1 Immunological detection of rna:dna hybrids on microarrays
10/26/2005EP1151010B1 Human polyclonal antibodies from transgenic nonhuman animals
10/26/2005CN1688692A Cell proliferation inhibitors containing anti-glypican 3 antibody
10/26/2005CN1688604A Recombinant anti-osteopontin antibody and use thereof
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688602A Novel MHC II associated peptides
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688338A Method of humanizing immune system molecules
10/26/2005CN1688337A Use of digoxin immune FAB (ovine) for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
10/26/2005CN1687136A Coupled substance between Lidamycin and segments of monoclonal antibody 3G11, 3G11Fab'
10/26/2005CN1687135A Monoclonal antibody for anti pig growth hormone, preparation process and application
10/26/2005CN1687134A Helicobacter pylori HpaA and monoclonal antibody ureB, immunoassay and diagnosis kit
10/26/2005CN1687133A Monoclonal antibody of anti human immune deficiency virus I type 24 protein and application thereof
10/26/2005CN1224712C Vector
10/26/2005CN1224710C Novel human lysozyme gene, its encoding polypeptide and the method for preparing them
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958320 Sel-12 related methods
10/25/2005US6958235 Recombinant protein containing a C-terminal fragment of plasmodium MSP-1
10/25/2005US6958219 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone
10/25/2005US6958152 Human phospholipase C delta 5
10/20/2005WO2005097998A2 Il-18 specific polypeptides and therapeutic uses thereof
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097832A2 Humanized anti-tgf-beta antibodies
10/20/2005WO2005097831A2 Uses of isolated binding members capable of binding specifically to secretagogues
10/20/2005WO2005097830A2 Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds
10/20/2005WO2005097211A2 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097187A2 Methods of preventing uvb-induced skin damage
10/20/2005WO2005097185A2 Irta-5 antibodies and their uses
10/20/2005WO2005097184A2 Antibodies against nogo receptor
10/20/2005WO2005097183A2 Treatment of diseases
10/20/2005WO2005097162A2 Steroid sparing agents and their use
10/20/2005WO2005097160A2 Modulation of nkg2d
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005087177A3 Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same
10/20/2005WO2005083431A3 Binding agents
10/20/2005WO2005060520A3 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF
10/20/2005WO2005057176A3 Method for identification of enzymes
10/20/2005WO2005056600A3 Monoclonal antibodies that bind or neutralize dengue virus
10/20/2005WO2005052006A3 Mutated anti-cd22 antibodies and immunoconjugates
10/20/2005WO2005049800A3 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
10/20/2005WO2005040217B1 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions
10/20/2005WO2005040216A3 Use of metallic cations to improve functional activity of antibodies
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005019267A3 Tie1-binding ligands
10/20/2005WO2005007198A3 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa
10/20/2005WO2004090544A3 Detection, characterization and treatment of viral infection and methods thereof
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234247 New effector conjugates, process for their production and their pharmaceutical use
10/20/2005US20050234226 Persephin and related growth factors
10/20/2005US20050234225 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
10/20/2005US20050234224 Enhanced precipitation and analysis of cryoglobulins
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233960 Methods and compositions for inhibiting c-met dimerization and activation
10/20/2005US20050233958 Using tumor necrosis factor receptor to identify modulators for prevention and treatment of cell proliferative disorders
10/20/2005US20050233429 vector and host cell comprising nucleic acid of invention; nucleic acid sequence encoding cyclcooxygenase-1 variant
10/20/2005US20050233417 Growth hormone variations in humans and their uses
10/20/2005US20050233411 Compositions and methods for cleaving IAP
10/20/2005US20050233392 Diagnosis of hepatocellular carcinoma
10/20/2005US20050233385 Using antibodies on cell surfaces
10/20/2005US20050233382 Polypeptide variants with altered effector function
10/20/2005US20050233374 Reagents and methods useful for detecting diseases of the prostate
10/20/2005US20050233371 CNG2B: a novel human cyclic nucleotide-gated ion channel
10/20/2005US20050233368 Canine pancreatic lipase
10/20/2005US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor
10/20/2005US20050233355 Human cDNAs encoding polypeptides having kinase functions
10/20/2005US20050233316 Monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy
10/20/2005US20050233311 Family of picornaviruses
10/20/2005US20050232942 Virulence genes, proteins, and their use
10/20/2005US20050232940 Recombinant plasmid and a method of controlling the effects of yersinia pestis
10/20/2005US20050232937 Paramycobacterial diagnostics and vaccines
10/20/2005US20050232931 Chimeric protein; induction apoptosis; anticancer agents; vaccine
10/20/2005US20050232929 detect, screen, and quantitate biological samples after administration of antibody conjugates, antibody-drug conjugates, antibodies, and fragments and metabolites thereof, by affinity separation, chromatography, and mass spectrometry; monomethyl auristatin drug and a thio-ether linkage
10/20/2005US20050232928 Drug conjugates
10/20/2005US20050232927 Using notch gene expression as evaluative tool in detecting breast cancer
10/20/2005US20050232926 Expressed in melanoma, breast cancer and hepatocellular carcinoma; fab fragments; fv fragments; competitive binding; for inducing caspase mediated apoptosis; neoplasm diagnosis
10/20/2005US20050232924 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
10/20/2005US20050232923 Methods and compositions for treating MCP-1 related pathologies
10/20/2005US20050232922 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
10/20/2005US20050232921 Immunoglobulin mixture specific to endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents
10/20/2005US20050232920 Inhibition of complement activation
10/20/2005US20050232919 Monoclonal antibodies that specifically block biological activity of a tumor antigen
10/20/2005US20050232918 Differentially expressed genes associated with obesity and type 2 diabetes
10/20/2005US20050232917 Antibodies to MAdCAM
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2563313A1 Modulation of nkg2d
10/20/2005CA2562223A1 Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged with hiv immunogen
10/20/2005CA2561947A1 Preventives/remedies for cancer
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1494